The animal healthcare market comprises veterinary pharmaceuticals and veterinary devices. Veterinary pharmaceuticals include vaccines, parasiticides, anti-infectives, medications for pain, dermatological products, and other pharmaceuticals that are used to prevent and treat diseases in animals. Veterinary devices include monitoring and imaging devices such as X-Ray and ultrasound equipment that help in disease diagnosis as well as surgical instruments used in animal surgery. These products are used for the healthcare of both companion animals and food-producing animals. Growing companionship between humans and companion animals such as dogs and cats has significantly driven the adoption of animal healthcare products over the years. It is estimated that there are over 850 million pet dogs and 470 million pet cats globally. The global animal healthcare Market is estimated to be valued at US$ 50.45 Bn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
The animal healthcare market is expected to be flourished by the growing companionship between humans and companion animals. Companion animal ownership has substantial growth opportunities for veterinary healthcare products. According to the American Pet Products Association, in 2021, 73.6% of North American households owned a pet, up from 62.5% in 1988. Growing pet health expenditure also supports the increased demand for animal healthcare services and products. Pets are now considered as family members in most households due to which pet owners are highly inclined to spend on animal healthcare to ensure long and healthy lives of pets. Increasing adoption of livestock animals in the Asia Pacific region driven by rising meat consumption also drives the demand for agriculture animal healthcare products for disease prevention and treatment of livestock animals. Rising livestock healthcare expenditure especially in China and India supports the growth of the animal healthcare market in the region over the forecast period.

Segment Analysis
The global animal healthcare market is segmented into companion animal and livestock. The companion animal segment dominates the market and accounts for over 60% share of the total market. This is because companion animals such as dogs and cats are like family members to many households across the world and people are willing to spend more on the healthcare of their pets. Within the companion animal segment, the dogs sub-segment holds the major market share owing to the rising pet dog population around the world and growing expenditure on dog health and nutrition products.

PEST Analysis
Political: Governments of various countries have implemented stringent regulations regarding the usage of antibiotics and growth promoters in animal feed. This is positively impacting the demand for alternative animal medications.
Economic: Rising disposable incomes and growing awareness about animal health is driving the overall spend on animal healthcare products and services globally. Developing economies in Asia Pacific are witnessing high economic growth which is supporting the market expansion.
Social: People are increasingly treating their pets as family members. This is resulting in humanization of pets and improved focus on pet nutrition, grooming, and preventive healthcare. Also, conscious owners prefer organic and natural medications for their animals.
Technological: Adoption of advanced diagnostics devices and rapid testing kits help improve disease management and treatment outcomes for animals. Technologies like pet microchipping are also gaining traction.

Key Takeaways
The Global Animal Healthcare Market is expected to witness high growth at a CAGR of 6.6% during the forecast period of 2023 to 2030.

Regionally, the Asia Pacific market is projected to grow the fastest owing to rising pet adoption, increasing meat consumption, and growing livestock population in countries like India and China.

Key players operating in the animal healthcare market are Abbott, Pfizer Inc., Eli Lilly & Company, Endo International plc, F. Hoffmann-La Roche AG Bausch Health Companies Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Johnson & Johnson Private Limited, GSK plc., Purdue Pharma L.P. Abbott holds the leading market share in the therapeutic category while Zoetis dominates the vaccine segment. The market players are focusing on developing novel drugs and vaccines to expand their product portfolio and strengthen market presence.

For more details on the report, Read- https://www.pressreleasebulletin.com/animal-healthcare-market-demand-share-analysis/

Get more insights on this topic: https://shoutingstars.com/automotive-embedded-systems-future-of-in-vehicle-technology